Anthracycline-induced cardiotoxicity: risk assessment and management.
Abu-Khalaf
Maysa M
MM
Breast Cancer Program, Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, USA.
Harris
Lyndsay
L
D018943:Anthracyclines / Q000009:adverse effects*; D006331:Heart Diseases / Q000139:chemically induced* / Q000517:prevention & control*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D018570:Risk Assessment
D018943:Anthracyclines